Arovella Therapeutics Limited Receivables

Arovella Therapeutics Limited (ALA.AX) currently reports a receivables of $530K as of June 2021. That compares with $870K in the prior-year period — down 38.6% year over year. Use the charts on this page to explore Arovella Therapeutics Limited's receivables history and peer comparisons.

Arovella Therapeutics Limited's receivables decreased from $870K to $530K — a 38.6% year-over-year decrease (period ending June 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Arovella Therapeutics Limited reported $530K in receivables as of June 2021. That compares with $870K in the prior-year period — down 38.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $530K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Arovella Therapeutics Limited, and consider following ALA.AX for alerts when major investors trade the stock.

Arovella Therapeutics Limited is classified in the Healthcare sector. On receivables, it currently shows $530K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALA.AX with unrelated industries.